{"name":"ProQuest Investments","permalink":"proquest-investments","crunchbase_url":"http://www.crunchbase.com/financial-organization/proquest-investments","homepage_url":"http://www.proquestvc.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"609-919-3560","description":"Healthcare-focused Venture","email_address":"","number_of_employees":null,"founded_year":1998,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Fri Apr 10 16:36:06 UTC 2009","updated_at":"Wed Jul 15 23:09:52 UTC 2009","overview":"<p>Founded in 1998, ProQuest Investments is a healthcare venture capital firm with over $875 million under management. We have 12 deal professionals and three offices, our headquarters in Princeton, and additional offices in San Diego and Montreal.</p>\n\n<p>We invest in healthcare companies seeking financings ranging from seed to late-stage. Our portfolio reflects the rich diversity of the healthcare industry and exemplifies our commitment to fostering the growth of exceptional businesses. In addition to our breadth of experience across many sectors of the healthcare industry, we have special expertise in therapeutics, where innovations in drug discovery technologies and molecular analysis are transforming an enormous unmet medical need. With a proven superior track record and over 40 investments in such diverse therapeutic categories as oncology, pain and infectious disease, ProQuest Investments seeks to build long term, mutually beneficial partnerships with outstanding entrepreneurs.</p>\n\n<p>At the end of 2006, ProQuest Investments closed its fourth fund of $425 million. </p>","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],[[236,79],"assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],[[236,79],"assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"90 Nassau Street","address2":"Fifth Floor ","zip_code":"08542","city":"Princeton","state_code":"NJ","country_code":"USA","latitude":40.349914,"longitude":-74.660045}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/2009/04/08/aerovance-inhales-38m-for-asthma-drugs/","source_description":"Aerovance inhales $38M for asthma drugs","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/clovis-oncology-inc-series-a-145m/","source_description":"Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development","raised_amount":145000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":26,"company":{"name":"Clovis Oncology","permalink":"clovis-oncology","image":{"available_sizes":[[[150,39],"assets/images/resized/0017/8043/178043v1-max-150x150.png"],[[250,65],"assets/images/resized/0017/8043/178043v1-max-250x250.png"],[[262,69],"assets/images/resized/0017/8043/178043v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/36623/orthocon-raises-25-million/","source_description":"Orthocon Raises $25 Million","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":8,"company":{"name":"Orthocon","permalink":"orthocon","image":{"available_sizes":[[[150,28],"assets/images/resized/0004/0829/40829v1-max-150x150.png"],[[229,44],"assets/images/resized/0004/0829/40829v1-max-250x250.png"],[[229,44],"assets/images/resized/0004/0829/40829v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://zosanopharma.com/index.php?option=com_content&task=view&id=9&Itemid=93","source_description":"Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million","raised_amount":90000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":15,"company":{"name":"Zosano Pharma","permalink":"zosano-pharma","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/2868/52868v1-max-150x150.jpg"],[[250,92],"assets/images/resized/0005/2868/52868v1-max-250x250.jpg"],[[267,99],"assets/images/resized/0005/2868/52868v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.leadtherapeutics.com/pr/2007/pr_110507.html","source_description":"LEAD Therapeutics Raises $17 Million in Series A Financing","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":5,"company":{"name":"LEAD Therapeutics","permalink":"lead-therapeutics","image":{"available_sizes":[[[150,120],"assets/images/resized/0005/2996/52996v1-max-150x150.jpg"],[[162,130],"assets/images/resized/0005/2996/52996v1-max-250x250.jpg"],[[162,130],"assets/images/resized/0005/2996/52996v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/zosano-pharma-inc-series-b-30m/","source_description":"Zosano Pharma, Inc.: Series B $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":6,"company":{"name":"Zosano Pharma","permalink":"zosano-pharma","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/2868/52868v1-max-150x150.jpg"],[[250,92],"assets/images/resized/0005/2868/52868v1-max-250x250.jpg"],[[267,99],"assets/images/resized/0005/2868/52868v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.biosyntech.com/en/newsroom/press.aspx?ID=119","source_description":"BioSyntech Announces $4.5 Million Financing","raised_amount":1400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":14,"company":{"name":"Biosyntech","permalink":"biosyntech","image":{"available_sizes":[[[150,93],"assets/images/resized/0006/1162/61162v1-max-150x150.png"],[[210,131],"assets/images/resized/0006/1162/61162v1-max-250x250.png"],[[210,131],"assets/images/resized/0006/1162/61162v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.gloucesterpharma.com/press/releases/pr082509.html","source_description":"Gloucester Pharmaceuticals Completes $29 Million Financing","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":25,"company":{"name":"Gloucester Pharmaceuticals","permalink":"gloucester-pharmaceuticals","image":{"available_sizes":[[[150,73],"assets/images/resized/0006/2317/62317v1-max-150x150.jpg"],[[236,115],"assets/images/resized/0006/2317/62317v1-max-250x250.jpg"],[[236,115],"assets/images/resized/0006/2317/62317v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.siliconindia.com/shownews/Gemin_X_Pharmaceuticals_closes_38_Mn_Series_C_financing-nid-43319.html","source_description":"Gemin X Pharmaceuticals closes $38 Mn Series C financing","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":3,"company":{"name":"Gemin X Pharmaceuticals","permalink":"gemin-x-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0007/9935/79935v1-max-150x150.jpg"],[[250,68],"assets/images/resized/0007/9935/79935v1-max-250x250.jpg"],[[263,72],"assets/images/resized/0007/9935/79935v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://excaliard.com/news/ISIS_News_2007_11_27_General_Releases.pdf","source_description":"Excaliard closes $15.5 million Series A financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners","raised_amount":15500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":27,"company":{"name":"Excaliard Pharmaceuticals","permalink":"excaliard-pharmaceuticals","image":{"available_sizes":[[[150,38],"assets/images/resized/0008/0196/80196v1-max-150x150.jpg"],[[250,64],"assets/images/resized/0008/0196/80196v1-max-250x250.jpg"],[[450,115],"assets/images/resized/0008/0196/80196v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/tragara-pharmaceuticals-inc-series-b-5m/","source_description":"Tragara Pharmaceuticals, Inc.: Series B $5M ","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":15,"company":{"name":"Tragara","permalink":"tragara","image":{"available_sizes":[[[150,41],"assets/images/resized/0004/8401/48401v1-max-150x150.jpg"],[[207,57],"assets/images/resized/0004/8401/48401v1-max-250x250.jpg"],[[207,57],"assets/images/resized/0004/8401/48401v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/predictive-biosciences-inc-series-c-25m/","source_description":"Predictive Biosciences, Inc.: Series C $25M","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":18,"company":{"name":"Predictive Biosciences","permalink":"predictive-biosciences","image":{"available_sizes":[[[150,44],"assets/images/resized/0007/2674/72674v1-max-150x150.png"],[[232,69],"assets/images/resized/0007/2674/72674v1-max-250x250.png"],[[232,69],"assets/images/resized/0007/2674/72674v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.mersana.com/news-events/news_11-08-05_mersana-21million-financing.pdf","source_description":"Mersana Therapeutics, Inc. Completes $21 Million Financing","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":8,"company":{"name":"Mersana Therapeutics","permalink":"mersana-therapeutics","image":{"available_sizes":[[[150,60],"assets/images/resized/0009/2309/92309v1-max-150x150.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-250x250.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":13970000,"raised_currency_code":"USD","funded_year":2005,"funded_month":7,"funded_day":19,"company":{"name":"EUSA Pharma","permalink":"eusa-pharma","image":{"available_sizes":[[[150,33],"assets/images/resized/0005/9049/59049v2-max-150x150.png"],[[250,55],"assets/images/resized/0005/9049/59049v2-max-250x250.png"],[[263,58],"assets/images/resized/0005/9049/59049v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/revision-optics-inc-series-d-35m/","source_description":"ReVision Optics, Inc.: Series D $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":20,"company":{"name":"ReVision Optics","permalink":"revision-optics","image":{"available_sizes":[[[150,74],"assets/images/resized/0009/4510/94510v2-max-150x150.jpg"],[[160,79],"assets/images/resized/0009/4510/94510v2-max-250x250.jpg"],[[160,79],"assets/images/resized/0009/4510/94510v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.xconomy.com/seattle/2010/07/26/immune-design-nabs-32m-for-targeted-vaccines/","source_description":"Immune Design Nabs $32M for Targeted Vaccines","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":26,"company":{"name":"Immune Design","permalink":"immune-design","image":{"available_sizes":[[[150,40],"assets/images/resized/0009/5060/95060v1-max-150x150.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-250x250.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/telormedix-sa-series-b-83m/","source_description":"Telormedix, SA.: Series B $8.3M","raised_amount":8300000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":28,"company":{"name":"Telormedix","permalink":"telormedix","image":{"available_sizes":[[[150,58],"assets/images/resized/0016/9590/169590v1-max-150x150.jpg"],[[206,80],"assets/images/resized/0016/9590/169590v1-max-250x250.jpg"],[[206,80],"assets/images/resized/0016/9590/169590v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.mevion.com/news/61-leading-private-venture-capital-firms-invest-45-million-in-mevion-medical-systems","source_description":"Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems ","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":24,"company":{"name":"Mevion Medical Systems","permalink":"mevion-medical-systems","image":{"available_sizes":[[[150,34],"assets/images/resized/0017/1598/171598v1-max-150x150.png"],[[250,57],"assets/images/resized/0017/1598/171598v1-max-250x250.png"],[[415,96],"assets/images/resized/0017/1598/171598v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/07/agile-therapeutics-closes-40m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Agile Therapeutics Closes $40M Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":19,"company":{"name":"Agile Therapeutics","permalink":"agile-therapeutics","image":{"available_sizes":[[[150,85],"assets/images/resized/0009/0629/90629v1-max-150x150.jpg"],[[201,114],"assets/images/resized/0009/0629/90629v1-max-250x250.jpg"],[[201,114],"assets/images/resized/0009/0629/90629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/07/mersana-therapeutics-raises-27m-series-a-1-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Mersana Therapeutics Raises $27M in Series A-1 Financing","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":31,"company":{"name":"Mersana Therapeutics","permalink":"mersana-therapeutics","image":{"available_sizes":[[[150,60],"assets/images/resized/0009/2309/92309v1-max-150x150.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-250x250.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}